OneStart | Blog

Learn why Lynne Murray from MedImmune is involved with OneStart 2016 and how she thinks that the extensive mentorship provided is the true prize of the OneStart programme.   -----   MedImmune is the worldwide biologics division of AstraZeneca, and... Read more >


Learn why Matthew Foy, from SR One, the corporate venture capital arm of GlaxoSmithKline (GSK) who co-founded OneStart in collaboration with Oxbridge Biotech Roundtable (OBR), thinks you should apply to OneStart 2016. ----- As a Venture Capital firm, we have... Read more >


We're counting down the days to the opening of applications to OneStart 2016, the world's premier life sciences and healthcare accelerator programme for budding entrepreneurs.    With the estimated value of many companies now rocketing into the billions, we’re here to facilitate your... Read more >


A London-based startup tackling Parkinson’s with new medicines to prevent neurodegeneration and a Utah-based company developing a surgical device to allow complete healing of ligament and tendon injuries have each claimed £100k/$150k non-dilutive funding and free lab space for six... Read more >


LONDON – In the most competitive year of OneStart yet, the 20 finalist startups – 10 from the Americas, and 10 from Europe and the rest of the world – have now been selected by our expert judging panel. Each... Read more >


We've selected the top 10 takeaways presented at the two-day OneStart Bootcamp in London by experienced speakers from SR One, Johnson & Johnson Innovation, Takeda Ventures, and more. From right to left, Jens Eckstein, President of SR One chairs the... Read more >


Collected here are all of the seminars and panel discussions of the OneStart 2015 London Biotech Bootcamp. Scroll down to browse through: Ilan Zipkin, Takeda Ventures - Development Paths in the Life Sciences Panel Discussion: Health Economics & Understanding Payers• Eli Gajraj,... Read more >


Unless you have somehow flouted the OneStart rules, you have probably never negotiated a term sheet or had to think about building enterprise value. In fact, running a company will require competencies new to you and some of those competencies... Read more >


Venture (noun): A risky or daring journey or undertaking. A business enterprise involving considerable risk. As in, “nothing ventured, nothing gained.” The label “venture capital” often evokes images of ruthless financial engineers who take advantage of innovative entrepreneurs, along the... Read more >


Fundraising is one of the most challenging aspects in your role as an entrepreneur. There are a myriad of options available to finance your business and enable its growth from an initial idea through to a business success story. There... Read more >


The OneStart life sciences and healthcare accelerator, organised by SR One and the Oxbridge Biotech Roundtable (OBR) received almost 650 applications from around the world, more than tripling from last year.LONDON – Now in it’s third year, the mission of OneStart... Read more >


Guest contribution by Olswang LLP, @OlswangOlswang LLP is a partner of OneStart, the world's largest life sciences & health care accelerator, organised by SR One and the Oxbridge Biotech Roundtable. Applications for OneStart 2015 closed on 1 December 2014: learn more at oxbridgebiotech.com/onestartIn our previous blog post,... Read more >


638 early-stage life science startups representing 50 countries have applied to OneStart 2015 to vie for non-dilutive prizes of £100k/$150k and free lab space. LONDON – The Oxbridge Biotech Roundtable and SR One are thrilled to announce the largest and... Read more >


Guest contribution by Eliot Forster, Executive Chair of MedCity, @MedCityHQMedCity is a partner of OneStart, the world's largest life sciences & health care accelerator, organised by SR One and the Oxbridge Biotech Roundtable. Apply by 1 December 2014 to win £100k/$150k non-dilutive funding for your startup... Read more >